Cargando…
Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapy
The dysregulation of apoptosis contributes in a variety of ways to the malignant phenotype. It is increasingly recognized that the alteration of pro-apoptotic and anti-apoptotic molecules determines not only escape from mechanisms that control cell cycle and DNA damage, but also endows the cancer ce...
Autores principales: | Gómez-Navarro, Jesús, Arafat , Waleed, Xiang, Jialing |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC521212/ https://www.ncbi.nlm.nih.gov/pubmed/11250691 http://dx.doi.org/10.1186/bcr27 |
Ejemplares similares
-
Direct targeting of amplified gene loci for pro-apoptotic anticancer therapy
por: Tiwari, Meetu Kaushik, et al.
Publicado: (2022) -
Gene therapy for carcinoma of the breast: Genetic immunotherapy
por: Strong, Theresa V
Publicado: (2000) -
Gene therapy for carcinoma of the breast: Genetic toxins
por: Vassaux, Georges, et al.
Publicado: (2000) -
Role of nanotechnology and gene delivery systems in TRAIL-based therapies
por: Naoum, George E, et al.
Publicado: (2016) -
Resveratrol, Epigallocatechin Gallate and Curcumin for Cancer Therapy: Challenges from Their Pro-Apoptotic Properties
por: Chimento, Adele, et al.
Publicado: (2023)